Donald Burkindine
Geriatric Medicine Marshfield, MO Doctor of Osteopathy
NPI 1245235498 CMS profile 939550
543 W Hubble Dr, Marshfield, MO 65706
General payments
$85
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$11,597,434
Through program year 2021, Donald Burkindine of Marshfield, MO is reported in the CMS Open Payments database as having received $85 across 6 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $11,597,434 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 34th percentile of Geriatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2021 | General | $18 | 1 | |
| 2020 | General | $12 | 1 | |
| 2019 | General | $54 | 4 |
Beside peers
- Donald Burkindine
- Geriatric Medicine median
- Middle half of Geriatric Medicine
- National median
In program year 2025, general payments to Donald Burkindine were reported at $0. Among 512 Geriatric Medicine profiles paid that year, the median was $120 and the middle half received between $37 and $350.
Show as a table
| Year | Donald Burkindine | Geriatric Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $54 | $96 | $28–$339 | $163 |
| 2020 | $12 | $99 | $28–$262 | $114 |
| 2021 | $18 | $94 | $27–$318 | $132 |
| 2022 | $0 | $103 | $34–$338 | $149 |
| 2023 | $0 | $109 | $39–$320 | $160 |
| 2024 | $0 | $125 | $36–$371 | $164 |
| 2025 | $0 | $120 | $37–$350 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 14 drugsPart D claims
336
Drug cost
$19,072
Branded share of claims
23.5%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 22 | $7,872 | |
| Linzess Linaclotide | Brand | 12 | $6,898 | |
| Trospium Chloride | Generic | 22 | $925 | |
| Baclofen | Generic | 22 | $601 | |
| Haloperidol | Generic | 23 | $587 | |
| Atorvastatin Calcium | Generic | 67 | $492 | |
| Bupropion Xl Bupropion Hcl | Brand | 23 | $411 | |
| Levothyroxine Sodium | Generic | 27 | $274 | |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | Brand | 22 | $236 | |
| Topiramate | Generic | 23 | $231 |
The 10 drugs with the highest cost, of 14 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 699 Part D prescribers listed as Family Medicine; they describe a distribution and say nothing about conduct.
Records
6 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Geriatric Medicine in Missouri
Srinath Tadakamalla
Geriatric Medicine · Harrisonville, MO
Randall Halley
Geriatric Medicine · Columbia, MO
William Knapp
Geriatric Medicine · Florissant, MO
William Rosen
Geriatric Medicine · Springfield, MO
Timothy Wilson
Geriatric Medicine · Kansas City, MO
Mahmoud Mansour
Geriatric Medicine · Columbia, MO
Related records
Geriatric Medicine in Missouri
Practitioners in the same specialty and state, ranked by reported value.
All Geriatric Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Missouri
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.